In January 2024, the FDA proposed a rule that would prevent BPC-157 from being used in compounding, classifying it alongside other peptides that lack adequate safety and efficacy data for compounded use 3
F1000Res, doi: 10.12688/f1000research.11775.1.
It is naturally produced in humans and found in the hypothalamus, pituitary, gut, plasma, cerebrospinal fluid, and breast milk, with levels following a circadian rhythm peaking in the late afternoon
DDA, Data Dependent Analysis algorithm
Washington (DC: National Academy of Sciences (2015)
Experimentally it has been demonstrated to accelerate the healing of many different wounds, including tendons, muscles, nervous system and superior healing of damaged ligaments